| Empyema n = 10 | Empyema + NP n = 25 | p-value |
Age (year) | 3.0 [0.6 to 8.1] | 3.6 [0.8 to 10.2] | 0.99 |
Gender female | 2/10 (20.0%) | 11/25 (44.0%) | 0.26 |
Weight (standard deviation) | 0.25 [−1.50 to 3.00] | 0.25 [−1.50 to 3.00] | 0.59 |
Past pulmonary medical history | 0 (0.0%) | 4/25 (16.0%) | 0.30 |
Concomitant extra-pulmonary infection | 3/10 (30.0%) | 6/25 (24.0%) | 0.69 |
Anti-pneumococcal vaccine pneumocoquevaccine = yes = 1, 2, 3 | 3/10 (30.0%) | 11/21 (52.4%) | 0.28 |
Symptoms |
|
|
|
Fever | 9/9 (100.0%) | 24/25 (96.0%) | 1 |
Cough | 5/10 (50.0%) | 20/25 (80.0%) | 0.11 |
Dyspnea | 2/10 (20.0%) | 5/25 (20.0%) | 1 |
Lethargy | 9/10 (90.0%) | 22/25 (88.0%) | 1 |
Chest pain | 3/10 (30.0%) | 2/25 (8.0%) | 0.13 |
Abdominal pain | 4/10 (40.0%) | 10/25 (40.0%) | 1 |
Clinical features |
|
|
|
Tachycardia | 6/9 (66.7%) | 15/23 (65.2%) | 1 |
Tachypnea | 10/10 (100.0%) | 23/24 (95.8%) | 1 |
Hypoventilation | 7/10 (70.0%) | 20/25 (80.0%) | 0.66 |
Rales | 2/10 (20.0%) | 8/25 (32.0%) | 0.69 |
Tubular sounds | 4/10 (40.0%) | 7/25 (28.0%) | 0.69 |
Wheezing | 2/10 (20.0%) | 1/25 (4.0%) | 0.19 |
SpO2 < 92% | 1/10 (10.0%) | 2/19 (10.6%) | 1 |